Einstein in the Media | U.S./Global

New York Times interviews Kartik Chandran, Ph.D., about new research that found the experimental Ebola drug ZMapp was successful in treating monkeys infected with the virus. The drug was used to treat two American aid workers infected during the current West African outbreak. Dr. Chandran notes the preliminary results were astounding as following treatment all the monkeys were healthy. Dr. Chandran is associate professor of microbiology & immunology and holds the Harold and Muriel Block Faculty Scholar in Virology (Tuesday, September 02, 2014)

More coverage on Dr. Chandran | Dr. Chandran's Profile

 
 

New York Times interviews Kami Kim, M.D., about research that finds the parasite Toxoplasma gondii can manipulate the behavior of its host by switching on genes in brain cells. Research by Dr. Kim has found that a number of pathogens, including leprosy, appear to use DNA methylation to turn genes on and off in the animal it infects. Dr. Kim is professor medicine, of microbiology & immunology and of pathology. (Friday, August 29, 2014)

Dr. Kim's Profile

 
 

CBSNews.com interviews Michael Lipton, M.D., Ph.D., about the FDA consumer alert for dietary supplements that falsely claim to prevent or cure concussions. Dr. Lipton notes that such claims may lead people to be less careful than they should and that the best way to prevent a concussion is to not have a head injury. Dr. Lipton is associate professor of radiology and associate director of the Gruss Magnetic Resonance Research Center at Einstein and medical director of MRI services at Montefiore Medical Center. (Wednesday, August 27, 2014)

More coverage on Dr. Lipton | Dr. Lipton's Profile

 
 

NY1 interviews Jonathan Lai, Ph.D., about his research on Ebola that focuses on developing antibodies to use as a possible treatment for all five strains of the virus. Dr. Lai notes that so far his lab has discovered antibodies that have proven protective in mice against the Sudan strain of the Ebola virus, but more research is required. Dr. Lai is associate professor of biochemistry. (Tuesday, August 19, 2014)

More coverage on this story | Dr. Lai's Profile

 
 

USA Today interviews Belinda Ostrowsky, M.D., about rapid detection tests for Ebola that are in development. The fastest reliable tests for Ebola currently take about three days, which can delay treatment. Dr. Ostrowsky notes that any rapid detection method would benefit patients and healthcare providers. Dr. Ostrowsky is associate professor of clinical medicine at Einstein and director of the Einstein-Montefiore Antibiotic Stewardship Program. (Friday, August 15, 2014)

Dr. Ostrowsky's Profile

 
 

NPR’s Morning Edition interviews Arturo Casadevall, M.D., Ph.D., on the controversy surrounding research on dangerous lab-made pathogens. Following the mishandling of smallpox by the CDC, the potential exposure of CDC scientists to live anthrax and even the recent the spread of Ebola, biologists and others are calling on the National Academy of Sciences to provide guidance on when and under what conditions research using lab-manipulated pathogens should be allowed to move forward. Dr. Casadevall is professor and chair of microbiology & immunology and the Leo and Julia Forchheimer Chair in Microbiology & Immunology at Einstein. (Dr. Casadevall’s interview begins at 4:38 in the audio version) (Wednesday, August 13, 2014)

More coverage on Dr. Casadevall | Dr. Casadevall's Profile

 
 

BBC’s Newshour interviews Tia Powell, M.D., on the ethics of using experimental drug treatments in light of the current Ebola outbreak. Dr. Powell notes that weighing the risks versus benefits of unproven drugs is a complex and time intensive process. She maintains that in order to contain the current crisis, the focus should be on proven public health safety measures, including quarantine and supportive care. Dr. Powell is director of the Montefiore Einstein Center for Bioethics and the Einstein-Cardozo Master of Science in Bioethics program. (Audio begins at 38:45) (Monday, August 11, 2014)

More coverage on Dr. Powell | Dr. Powell's Profile

 
 

The Washington Post reports on research by Joe Verghese, M.B.B.S., that predicts pre-dementia by measuring walking speed and cognitive abilities. The quick, low-tech test determined that 1 in 10 older adults have pre-dementia. The study involved 27,000 people in 7 countries. It found that those who had unusually slow walking speed and cognitive complaints are twice as likely to develop dementia within 12 years. Dr. Verghese is professor of neurology at Einstein and chief of the division of geriatrics at Einstein and Montefiore Medical Center. (Tuesday, August 05, 2014)

More coverage on this story | More coverage on Dr. Verghese | Dr. Verghese's Profile

 
 

ABC-TV’s Good Morning America interviews Keith Ayoob, Ed.D., about a new CDC report that found nearly 25 percent of parents underestimate their children’s weight. The study also found that 27 percent of children and teens underestimate their own weight. Dr. Ayoob notes parents often believe that their children will outgrow being overweight, which is unlikely, and cautions against waiting to make dietary and lifestyle changes. Dr. Ayoob is associate clinical professor of pediatrics and director of the nutrition clinic at the Children's Evaluation and Rehabilitation Center at Einstein. (Friday, August 01, 2014)

More coverage on Dr. Ayoob | Dr. Ayoob's Profile

 
 

The New York Times interviews Richard Lipton, M.D., about research from the Einstein Aging Study (EAS) which found an association between perceived stress and dementia. As part of two separate EAS studies, participants were surveyed about perceived stress. For healthy participants, cognitive loss was associated with scoring highest for stress and anxiety over a four-year period while the risk of dementia was two-and-a-half times greater for participants who had amnestic mild cognitive impairment and the highest perceived stress. Dr. Lipton is director of the Einstein Aging Study and vice chair of the Saul R. Korey Department of Neurology at Einstein and director of the division of cognitive aging and dementia at Montefiore Medical Center. (Wednesday, July 16, 2014)

More coverage on Dr. Lipton | Dr. Lipton's Profile

 
 

The Washington Post interviews Solomon Moshé, M.D., about the case of a girl with a rare form of epilepsy that causes uncontrolled bouts of laughter. Dr. Moshe notes that these gelastic seizures aren’t sparked by happiness and can actually be quite scary for the patient. Dr. Moshé is director of the division of pediatric neurology and professor in The Saul R. Korey Department of Neurology and The Dominick P. Purpura Department of Neuroscience at Einstein as well as chief of pediatric neurology at The Children’s Hospital at Montefiore. (Tuesday, June 24, 2014)

More coverage on this story | More coverage on Dr. Moshe | Dr. Solomon's Profile

 
 

New York Daily News interviews John Greally, M.B., B.Ch., Ph.D., about his study that found environmental influences may play a role in the development of autism. Dr. Greally identified epigenetic changes, which can control which genes are turned on or off, that may be implicated. Dr. Greally is professor of genetics, of medicine and of pediatrics, director of the Center for Epigenomics and the Ruth L. and David S. Gottesman Faculty Scholar for Epigenomics at Einstein and attending physician, pediatrics at The Children's Hospital at Montefiore. (Monday, June 02, 2014)

More coverage on this story | More coverage on Dr. Greally | Dr. Greally's Profile

 
 

The New York Times Magazine quotes Paul Frenette, M.D., in an article on research linking the nervous system to inflammation. Dr. Frenette has discovered that nerves play a key role in triggering prostate cancer, which is also associated with inflammation. Dr. Frenette is professor of medicine and of cell biology and director of the Ruth L. and David S. Gottesman Institute for Stem Cell and Regenerative Medicine Research. (Tuesday, May 27, 2014)

More coverage on Dr. Frenette | Dr. Frenette's Profile

 
 

New York Post covered Einstein’s Spirit of Achievement luncheon at the Plaza Hotel, which honored actor Christine Baranski (“The Good Wife”). Other honorees included Judy Aschner, M.D., Michael I. Cohen, M.D., University Chair of Pediatrics at Einstein and Montefiore (pictured), beauté’s Julie Macklowe and Gilt’s Alexandra Wilkis Wilson. Proceeds from the annual event benefit research in women’s and men’s cancers—including ovarian, lung, colon, prostate, cervical, uterine, pancreatic, breast cancer and leukemia. The event was hosted by the New York Chapter of the National Women’s Division. (Friday, May 16, 2014)

Dr. Aschner's Profile

 
 

The Washington Post interviews John Foxe, Ph.D., about his research with children who have difficulty processing sensory information, like sound and touch. Dr. Foxe's research, conducted with his collaborator Sophie Molholm, Ph.D., has shown that the brain wave patterns of children identified with having sensory processing disorder differ from those of typically developing children. Dr. Foxe is professor in the Dominick P. Purpura Department of Neuroscience and of pediatrics, and director of research at the Children’s Evaluation and Rehabilitation Center at Einstein. (Tuesday, May 13, 2014)

More coverage on Dr. Foxe | Dr. Foxe's Profile

 
 
First Page | Previous Page | Page of 13 | Next Page | Last Page